P3 Health Partners Inc. (PIII) Stock Forecast Nov. 6, 2026
Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
P3 Health Partners Inc. (PIII) stock forecast summary
Our AI scores P3 Health Partners Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
P3 Health Partners Inc. is a small-cap company with a market capitalization of $27M. It ranks number 9 by market capitalization among the 11 Services-Health Services issuers in our coverage with a current forecast. Its Current Ratio of 0.46x is the lowest of the 10 peers that report one. Its D/E Ratio of 7.16x is the highest of the 10 peers that report one.
For PIII, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 344 forecast dates between 2022-11-18 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 37.0%, measured on 387 forecast dates between 2022-11-18 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, PIII included.
PIII price chart and AI forecast
How PIII ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
P3 Health Partners Inc. (PIII) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Health Services peers listed below that report each metric.
Valuation & Market
| Metric | PIII | Rank |
|---|---|---|
| Market Cap | $27M | 9/11 |
| P/B Ratio | 0.38x | 8/9 |
| EPS | $-33.38 | – |
| Book Value/Share | $10.04 | – |
| Revenue/Share | $208.96 | – |
Profitability & Margins
| Metric | PIII | Rank |
|---|---|---|
| ROIC | -55.9% | 8/9 |
| Operating Margin | -9.9% | 7/10 |
| EBT Margin | -15.1% | 7/10 |
| Tax Rate | 4.7% | – |
Financial Health
| Metric | PIII | Rank |
|---|---|---|
| Current Ratio | 0.46x | 10/10 |
| D/E Ratio | 7.16x | 1/10 |
| Financial Leverage | 9.06x | 1/9 |
| Interest Coverage | -5.2x | 7/9 |
| Working Capital | -$209M | 9/9 |
Cash Flow
| Metric | PIII | Rank |
|---|---|---|
| Operating Cash Flow | -$131M | 10/10 |
Operational Efficiency
| Metric | PIII | Rank |
|---|---|---|
| Asset Turnover | 2.30x | 1/8 |
| Fixed Assets Turnover | 594.7x | 2/9 |
Income Statement
| Metric | PIII | Rank |
|---|---|---|
| Total Revenue | $1.50B | 3/9 |
| Operating Income | -$149M | 9/10 |
| SG&A Expense | $117M | 7/9 |
Dividend & Shareholder Information
| Metric | PIII | Rank |
|---|---|---|
| Shares Outstanding | 7M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $179M | 27.4% of assets |
| Cash & Short-term Investments | $21M | 3.3% of assets |
| Total Liabilities | $517M | 79.0% of assets |
| Short-term Debt | $381M | 58.2% of assets |
PIII quarterly financials and insider trading
P3 Health Partners Inc. (PIII) industry peers
Companies classified under the same SEC industry code as P3 Health Partners Inc. (Services-Health Services): 11 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| PIII P3 Health Partners Inc. | $27M | |
| LFST Lifestance Health Group, Inc. | $5.13B | |
| PRVA Privia Health Group, Inc. | $3.12B | |
| WGS Genedx Holdings Corp. | $1.86B | |
| USPH U S Physical Therapy Inc /Nv | $1.45B | |
| PNTG Pennant Group, Inc. | $1.27B | |
| INNV Innovage Holding Corp. | $1.22B | |
| OMDA Omada Health, Inc. | $924M | |
| EUDA Euda Health Holdings Ltd | $44M | |
| DCGO Docgo Inc. | $24M | |
| ATPC Agape Atp Corp | $1M |
Where PIII sits on the market map
P3 Health Partners Inc. (PIII) stock news
Loading...
P3 Health Partners Inc. (PIII) stock forecast FAQ
What is the P3 Health Partners Inc. (PIII) stock forecast?
Our AI scores P3 Health Partners Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.
How accurate are P3 Health Partners Inc. stock predictions?
For PIII, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 33.0%, measured on 344 forecast dates between 2022-11-18 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 37.0%, measured on 387 forecast dates between 2022-11-18 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are P3 Health Partners Inc. forecasts updated?
P3 Health Partners Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.
Which companies are P3 Health Partners Inc.'s industry peers?
11 issuers in our coverage, PIII included, share the SEC industry code Services-Health Services. The largest are: Lifestance Health Group, Inc. (LFST), Privia Health Group, Inc. (PRVA), Genedx Holdings Corp. (WGS), U S Physical Therapy Inc /Nv (USPH), Pennant Group, Inc. (PNTG), Innovage Holding Corp. (INNV).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.